1. PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP). (23rd June 2022) Authors: Hijiya, N.; Kapoor, S.; Hoch, M.; Descamps, L.; Bayar, M. A.; Ramscar, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗